CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary Cas13 has demonstrated unique and broad utility in RNA editing, nucleic acid detection, and disease diagnosis; however, a constantly active Cas enzyme may induce unwanted effects. Bacteriophage- or prophage regions-encoded anti-CRISPR (acr) molecules provide the potential to control targeting specificity and potency to allow for optimal RNA editing and nucleic acid detection by spatiotemporally modulating endonuclease activities. Using integrated approaches to screen acrVI candidates and evaluate their effects on Cas13 function, we discovered a series of acrVIA1–7 genes that block the activities of Cas13a. These VI-A CRISPR inhibitors substantially attenuate RNA targeting and editing by Cas13a in human cells. Strikingly, AcrVIAs also significantly muffle the single nucleic acid editing ability of the dCas13a RNA editing system. Mechanistically, AcrVIA1, 4, 5 and 6 bind LwaCas13a while AcrVIA2 and 3 can only bind LwaCas13-crRNA complex. These identified anti-CRISPR molecules may enable precise RNA-editing in Cas13-based application and studying phage-bacterium interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pfam protein families database in 2019
El-Gebali, S., Mistry, J., Bateman, A., Eddy, S. R., Luciani, A., Potter, S. C., Qureshi, M., Richardson, L. J., Salazar, G. A., Smart, A., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky995 · Cited by 4,602 · cited 1×
“Protein families database (Pfam) (El-Gebali et al., 2018) was used to identify the helix-turn-helix (HTH) domain as bona fide Acr-association (Aca) gene candidates in the predicted prophage regions, which act as the mark to screen the uncharacterized open reading frames (ORFs) as anti-CRISPR (Acr) candidates in the pr…”
MethodHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 1×
“Despite becoming the most useful tools for gene editing or regulation, the currently available Cas systems are imperfect due to the potential off-target effects, immunogenicity and cytotoxicity (Fu et al., 2013).”
RNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093
Diversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423 · cited 1×
“Six distinct types of CRISPR-Cas systems (I to VI) are currently described and are categorized into two classes (Koonin et al., 2017).”
BackgroundCRISPR-Cas guides the future of genetic engineering
Knott, G. J., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aat5011 · Cited by 1,410
Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos
Zuo, E., Sun, Y., Wei, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2019) · Science · doi:10.1126/science.aav9973 · Cited by 782 · cited 1×
“Excessive, prolonged Cas13 nuclease exposure may exacerbate undesirable RNA mutations and induce significant off-target effects, thus limiting CRISPR-based applicability and precision targeting addressing important safety concerns (Abudayyeh et al., 2017; Cullot et al., 2019; Montiel-Gonzalez et al., 2018; Zuo et al.,…”
BackgroundSmargon, A. A., Cox, D. B. T., Pyzocha, N. K., Zheng, K., Slaymaker, I. M., Gootenberg, J. S., Abudayyeh, O. A., Essletzbichler, P., Shmakov, S., Makarova, K. S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.023 · Cited by 575
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Cullot, G., Boutin, J., Toutain, J., Prat, F., Pennamen, P., Rooryck, C., Teichmann, M., Rousseau, E., Lamrissi-Garcia, I., Guyonnet-Duperat, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09006-2 · Cited by 474 · cited 1×
“Excessive, prolonged Cas13 nuclease exposure may exacerbate undesirable RNA mutations and induce significant off-target effects, thus limiting CRISPR-based applicability and precision targeting addressing important safety concerns (Abudayyeh et al., 2017; Cullot et al., 2019; Montiel-Gonzalez et al., 2018; Zuo et al.,…”
BackgroundCRISPR-Based Technologies: Impact of RNA-Targeting Systems
Terns, M. P. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.018 · Cited by 168
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Self-citationLopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82
A CRISPR way for accelerating cereal crop improvement: Progress and challenges
Basu, U., Riaz Ahmed, S., Bhat, B. A., Anwar, Z., Ali, A., Ijaz, A., Gulzar, A., Bibi, A., Tyagi, A., Nebapure, S. M., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.866976 · Cited by 51
Wang, Z., Guo, K., Gao, P., Pu, Q., Wu, M., Li, C., & Hur, J. (2020) · arXiv · doi:10.48550/arxiv.2005.07856 · Cited by 9
Self-citationAnti-CRISPR: A defense strategy of bacteriophages against bacteria
S, A., & Tanuj, G. (2020) · Journal of Entomology and Zoology Studies · doi:10.22271/j.ento.2020.v8.i6n.7968 · Cited by 5
Metadata
- Authors
- Lin, P., Qin, S., Pu, Q., Wang, Z., Wu, Q., Gao, P., Schettler, J., Guo, K., Li, R., Li, G., Huang, C., Wei, Y., Gao, G. F., Jiang, J., & Wu, M.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 78
- Issue
- 5
- Pages
- 850-861.e5
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W3018793124
- Cited by
- 93
- References
- 9
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells. https://app.cochat.ai/papers/10.1016/j.molcel.2020.03.033
- The paper
- Lin, P., Qin, S., Pu, Q., Wang, Z., Wu, Q., Gao, P., Schettler, J., Guo, K., Li, R., Li, G., Huang, C., Wei, Y., Gao, G. F., Jiang, J., & Wu, M. (2020). CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells. Molecular Cell. https://doi.org/10.1016/j.molcel.2020.03.033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.